MEI Pharma, Inc. (MEIP) Tops Q2 EPS by 22c

MEI Pharma, Inc. (NASDAQ: MEIP) reported Q2 EPS of $0.08, $0.22 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $32.74 million versus the consensus estimate of $5.29 million.

For earnings history and earnings-related data on MEI Pharma, Inc. (MEIP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• SanDisk upgraded at JPMorgan after investor day; shares climb